Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
NL0012044747
Fri, 19.12.2025
Redcare Pharmacy N.V.
Redcare Pharmacy: Redemption of 2021/2028 convertible bond.
Sevenum, the Netherlands, 19 December 2025. Bondholders of convertible bonds issued by Redcare Pharmacy N.V. (the “Convertible Bond”) with an initial volume of EUR 225 million, have exercised their rights pursuant to the terms and conditions of the Convertible Bond to redeem their bonds o [ … ]
Thu, 11.12.2025
Redcare Pharmacy N.V.
Redcare Pharmacy opens new online pharmacy for the Austrian market in Czechia.
Sevenum, the Netherlands, 11.12.2025 – Yesterday, Redcare Pharmacy inaugurated its new online pharmacy for the Austrian market in Pilsen, Czechia. With this new location, the company has created a key foundation to further accelerate growth in Europe.
The project was i [ … ]
Mon, 10.11.2025
Redcare Pharmacy N.V.
Change in Redcare Pharmacy´s Managing Board:
new CFO Hendrik Krampe.
Sevenum, the Netherlands, 10 November 2025. Redcare Pharmacy’s Supervisory Board has designated Hendrik Krampe as member of the Managing Board and Chief Financial Officer, effective 1 December 2025. He succeeds Jasper Eenhorst, who stepped down to pursue new professional opportun [ … ]
Wed, 29.10.2025
Redcare Pharmacy N.V.
Redcare Pharmacy: scaling Rx and strengthening operating cash generation with adj. EBITDA margin of 2.4% in Q3.
YTD total sales up 27% to EUR 2.1bn, +25% in Q3 to EUR 719M.
Non-Rx sales up 18% to EUR 1.4bn YTD and 17% in Q3 to EUR 447M; total Rx sales up 46% to EUR 758M YTD and 42% in Q3 to EUR 272M.
Rx sales Germany up 122% YTD to EUR 348M, Q3 [ … ]
Mon, 06.10.2025
Redcare Pharmacy N.V.
Redcare Pharmacy confirms full-year guidance following sustained positive Q3 sales performance in both Rx and non-Rx.
Total sales up 25% to EUR 719M in Q3.
YTD total sales up 27% or EUR 450M to EUR 2.15bn.
Non-Rx sales up 17% to EUR 448M in Q3; YTD 18% to EUR 1.4bn.
Rx sales in Germany up 82% to EUR 126M in Q3, YTD 122% and EUR 348M.
Numbe [ … ]
Fri, 26.09.2025
Redcare Pharmacy N.V.
Change in Redcare Pharmacy’s Managing Board: CFO Jasper Eenhorst to step down.
Sevenum, the Netherlands, 26 September 2025. After almost six years as CFO, Jasper Eenhorst will leave Redcare Pharmacy to take on new career opportunities. He is stepping down from the Managing Board today, but will remain with the company until the end of this year to [ … ]
Tue, 29.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s adjusted EBITDA margin in Q2 at a 12-month high of 2.6%, with continued strong sales growth of 26.5%.
Total sales up 26.5% YoY to EUR 709M in Q2, and 27% to EUR 1.4bn in H1.
Non-Rx sales up 17% to EUR 457M in Q2, and 18% to EUR 941M in H1.
Rx sales up 48% to EUR 252M in Q2, and 49% to EUR 486M in H1, of which generated in Ger [ … ]
Thu, 17.07.2025
Redcare Pharmacy N.V.
Rx bonus for EU mail order pharmacies confirmed by German Supreme Court ruling.
Sevenum, the Netherlands. 17 July 2025 – Today, the German Supreme Court (Bundesgerichtshof – BGH) affirmed the European Court of Justice (ECJ) ruling in lawsuit I ZR 74/24: Online pharmacies based in the EU are not bound by the German fixed prices for prescription [ … ]
Tue, 15.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology.
Sevenum, the Netherlands, 15 July 2025. Today Redcare Pharmacy was notified by its technology partner eHealth Experts that an extension until 31 January 2027 for its CardLink product license has been recei [ … ]
Thu, 03.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy confirms guidance for all elements after strong Q2 performance, with total sales growing 26.4%.
Total sales up 26.4% to EUR 709M in Q2 and 27.2% to EUR 1.4bn in H1.
Non-Rx sales up 17% to EUR 457M in Q2 and 18.3% to EUR 941M in H1. Impact from the shift of Easter from Q1 to Q2 is evened out in the H1 numbers.
Rx sales in Germa [ … ]
